c-Kit signaling potentiates CAR T cell efficacy in solid tumors by CD28- and IL-2-independent co-stimulation
Yuquan Xiong(Memorial Sloan Kettering Cancer Center), Prasad S. Adusumilli(Memorial Sloan Kettering Cancer Center)
Cited by 18
Related Papers
Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition
|Journal of Clinical Investigation|2016|1k
A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti–PD-1 Agent Pembrolizumab
|Cancer Discovery|2021|551
An engineered S1P chaperone attenuates hypertension and ischemic injury
|Science Signaling|2017|113